FdaApplication
NDA 209210
Identifiers
- fda_app_no: NDA209210
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA AB |
| application_type | NDA |
| approval_date | 2017-10-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BYDUREON BCISE | EXENATIDE SYNTHETIC | 2MG/0.85ML (2MG/0.85ML) | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS |
1 product